* Hikma’s offering of Buprenorphine and Naloxone Sublingual Film is limited to opioid treatment facilities and programs for their own use and not for release to other pharmacies or third parties.
† These products are covered under a REMS (Risk Evaluation and Mitigation Strategies) Program. Additional information for consumers and healthcare providers can be found at www.btodrems.com
Please visit hikma.com/us for additional product information, including the Full Prescribing Information with complete indications for use, warnings, precautions and adverse reactions for each product.
Product images may not reflect actual sizes and/or exact colors.
All other trademarks listed herein are the property of their respective owners and are used for illustrative purposes only. These trademark owners are not associated or affiliated with Hikma Pharmaceuticals USA, Inc.